Developing as a noteworthy breakthrough in the struggle against obesity, Retatrutide is attracting considerable buzz. It combines the action of two known GLP-1 receptor agonists, dulaglutide , and an unique glucose-dependent retatrutide hormonal component. Preliminary clinical results have shown substantial fat decrease in patients with excessive